A patient with mlaignant carcinoid syndrome was treated with a long-acting somatostatin analogue. The cutaneous and systemic improvement our patient had while receiving this therapy is described.
|Original language||English (US)|
|Number of pages||3|
|Journal||Archives of Dermatology|
|State||Published - Mar 1989|
ASJC Scopus subject areas